Article
The role of CRISPR-Cas9 and CRISPR interference technologies in the treatment of autoimmune diseases
10 Apr 2025
Abstract excerpt
Autoimmune disorders can be described as inappropriate immune responses directed against self-antigens, which account for substantial healthcare concerns around the world. Immunosuppression or immune modulation are the main therapeutic modalities for autoimmune disorders. These modalities, however, impair the ability of the immune system to fight against infections, thereby predisposing to opportunistic diseases....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
